Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations

Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations

Bernardo Leon Rapoport,1 Matti Aapro,2 Martin R Chasen,3 Karin Jordan,4 Rudolph M Navari,5 Ian Schnadig,6 Lee Schwartzberg7 1The Medical Oncology Centre of Rosebank, Johannesburg, South Africa; 2Breast Center, Genolier Cancer Center, Genolier, Switzerland; 3Palliative Care, William Osler Health Ser...

Full description

Bibliographic Details
Main Authors: Rapoport BL, Aapro M, Chasen MR, Jordan K, Navari RM, Schnadig I, Schwartzberg L
Format: Article
Language:English
Published: Dove Medical Press 2017-09-01
Series:Drug Design, Development and Therapy
Subjects:
Rolapitant
neurokinin-1 receptor antagonist
chemotherapy-induced nausea and vomiting
post hoc analyses
Online Access:https://www.dovepress.com/recent-developments-in-the-clinical-pharmacology-of-rolapitant-subanal-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/recent-developments-in-the-clinical-pharmacology-of-rolapitant-subanal-peer-reviewed-article-DDDT

Similar Items